Additionally, loss-of-function mutations of the TLR4 gene have been associated with inhibition of microglial and monocytic activation by accumulated amyloid peptide, leading to a decreased expression of the inflammatory markers (IL-6 and TNF-α) and nitric oxide, implicating TLR4 in the neuroinflammation of AD. This evidence concerns the gene TLR4 and Alzheimer disease.